ArticleCancer gene therapy2018

miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer.

Xinliang Zhou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.